- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
CannaRoyalty Gets Exclusive Rights for Infused Pre-Roll Brand
CannaRoyalty announced it obtained the exclusive rights to distribute and manufacture Pacific Remedy’s infused pre-rolls in California.
CannaRoyalty (CSE:CRZ) announced it obtained the exclusive rights to distribute and manufacture Pacific Remedy’s infused pre-rolls in California.
As quoted in the press release:
The Agreement also provides CannaRoyalty with the option to purchase global brand rights (the “Option”) for the premium infused pre-roll manufacturer.
“Brands are true value. Built through real consumer trust. They are our mission,” said Marc Lustig, Chairman & CEO, CannaRoyalty.
Pacific Remedy is a California-based brand founded by Timothy Elze and Jon Rivera. Pacific Remedy’s uniquely designed infused pre-rolls make them a differentiated manufacturer in the premium pre-roll category. In 2017, Pacific Remedy’s products were carried in 13 cannabis dispensaries throughout the Bay Area and Southern California. Subsequent to this Agreement, Pacific Remedy will be able to sell its premium product through CannaRoyalty’s distribution network, which covers the majority of California’s approximately 500 licensed dispensaries.
Source: www.newswire.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.